Contact this trialFirst, we need to learn more about you.
Subcutaneous vs Intravenous Nivolumab + Relatlimab for Melanoma
Recruiting1 awardPhase 2
San Francisco, California
This trial is testing two injection methods for cancer treatment to see which one patients prefer and to ensure they are safe. The treatments help the immune system attack cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service